AYTU BIOPHARMA, INC Derivative, Gain (Loss) on Derivative, Net
AYTU BIOPHARMA, INC (AYTU) reported Derivative, Gain (Loss) on Derivative, Net of -$4.73 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Income Statement › Other Income
us-gaap:DerivativeGainLossOnDerivativeNet · last filed 2026-09-22
- AYTU BIOPHARMA, INC derivative, gain (loss) on derivative, net for the quarter ending 2026-06-30 was $983.00K.
- AYTU BIOPHARMA, INC derivative, gain (loss) on derivative, net for the quarter ending 2026-03-31 was -$1.26M, a 155.59% decline year-over-year.
- AYTU BIOPHARMA, INC derivative, gain (loss) on derivative, net for the quarter ending 2025-12-31 was -$8.24M, a 373.34% decline year-over-year.
- AYTU BIOPHARMA, INC derivative, gain (loss) on derivative, net for the quarter ending 2025-09-30 was $3.78M, a 31.39% increase year-over-year.
- AYTU BIOPHARMA, INC derivative, gain (loss) on derivative, net for fiscal 2026 was -$4.73M.
- AYTU BIOPHARMA, INC derivative, gain (loss) on derivative, net for fiscal 2025 was -$1.70M.
- AYTU BIOPHARMA, INC derivative, gain (loss) on derivative, net for fiscal 2024 was -$4.00M, a 183.54% decline from fiscal 2023.
- AYTU BIOPHARMA, INC derivative, gain (loss) on derivative, net for fiscal 2023 was $4.79M, a 198.63% increase from fiscal 2022.
| Period end | Derivative, Gain (Loss) on Derivative, Net 3 month | Derivative, Gain (Loss) on Derivative, Net 6 month | Derivative, Gain (Loss) on Derivative, Net 9 month | Derivative, Gain (Loss) on Derivative, Net 12 month | Derivative, Gain (Loss) on Derivative, Net 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $983.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-22 | -$274.00K derived: sum of 2 quarters · filed 2026-09-22 | -$8.52M derived: sum of 3 quarters · filed 2026-09-22 | -$4.73M 10-K · filed 2026-09-22 | |
| 2026-03-31 | -$1.26M 10-Q · filed 2026-05-13 | -$9.50M derived: sum of 2 quarters · filed 2026-05-13 | -$5.72M 10-Q · filed 2026-05-13 | -$15.58M derived: sum of 4 quarters · filed 2026-09-22 | |
| 2025-12-31 | -$8.24M 10-Q · filed 2026-02-03 | -$4.46M 10-Q · filed 2026-02-03 | -$14.32M derived: sum of 3 quarters · filed 2026-09-22 | -$12.06M derived: sum of 4 quarters · filed 2026-09-22 | |
| 2025-09-30 | $3.78M 10-Q · filed 2025-11-13 | -$6.08M derived: sum of 2 quarters · filed 2026-09-22 | -$3.81M derived: sum of 3 quarters · filed 2026-09-22 | -$799.00K derived: sum of 4 quarters · filed 2026-09-22 | |
| 2025-06-30 | -$9.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-22 | -$7.60M derived: sum of 2 quarters · filed 2026-09-22 | -$4.58M derived: sum of 3 quarters · filed 2026-09-22 | -$1.70M 10-K · filed 2026-09-22 | |
| 2025-03-31 | $2.26M 10-Q · filed 2026-05-13 | $5.28M derived: sum of 2 quarters · filed 2026-05-13 | $8.16M 10-Q · filed 2026-05-13 | $9.62M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | $3.02M 10-Q · filed 2026-02-03 | $5.90M 10-Q · filed 2026-02-03 | $7.36M derived: sum of 3 quarters · filed 2026-02-03 | $8.38M derived: sum of 4 quarters · filed 2026-02-03 | |
| 2024-09-30 | $2.88M 10-Q · filed 2025-11-13 | $4.34M derived: sum of 2 quarters · filed 2025-11-13 | $2.88M 10-Q · filed 2024-11-13 | $4.78M derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $2.48M derived: sum of 2 quarters · filed 2025-09-23 | $1.90M derived: sum of 3 quarters · filed 2025-09-23 | -$4.00M 10-K · filed 2025-09-23 | |
| 2024-03-31 | $1.02M 10-Q · filed 2025-05-14 | $440.00K derived: sum of 2 quarters · filed 2025-05-14 | -$5.47M 10-Q · filed 2025-05-14 | -$6.84M derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | -$577.00K 10-Q · filed 2025-02-12 | -$6.48M 10-Q · filed 2025-02-12 | -$7.86M derived: sum of 3 quarters · filed 2025-02-12 | -$5.29M derived: sum of 4 quarters · filed 2025-02-12 | |
| 2023-09-30 | -$5.91M 10-Q · filed 2024-11-13 | -$7.28M derived: sum of 2 quarters · filed 2024-11-13 | -$5.91M 10-Q · filed 2024-11-13 | -$3.31M derived: sum of 4 quarters · filed 2024-11-13 | |
| 2023-06-30 | -$1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-26 | $1.20M derived: sum of 2 quarters · filed 2024-09-26 | $2.60M derived: sum of 3 quarters · filed 2024-09-26 | $4.79M 10-K · filed 2024-09-26 | |
| 2023-03-31 | $2.57M 10-Q · filed 2024-05-15 | $3.98M derived: sum of 2 quarters · filed 2024-05-15 | $6.17M 10-Q · filed 2024-05-15 | $7.78M derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $1.40M 10-Q · filed 2024-02-14 | $3.59M 10-Q · filed 2024-02-14 | $5.21M derived: sum of 3 quarters · filed 2024-02-14 | $5.20M derived: sum of 4 quarters · filed 2024-02-14 | |
| 2022-09-30 | $2.19M 10-Q · filed 2023-11-14 | $3.80M derived: sum of 2 quarters · filed 2023-11-14 | $3.80M derived: sum of 3 quarters · filed 2023-11-14 | ||
| 2022-06-30 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-12 | $1.60M derived: sum of 2 quarters · filed 2023-10-12 | $1.60M 10-K · filed 2023-10-12 | $211.00K 10-K · filed 2022-09-27 | |
| 2022-03-31 | -$7.00K 10-Q · filed 2023-05-11 | -$7.00K 10-Q · filed 2023-05-11 | |||
| 2021-06-30 | $0.00 10-K · filed 2022-09-27 | ||||
| 2020-09-30 | $0.00 10-Q · filed 2020-11-12 | $170.00 derived: sum of 2 quarters · filed 2021-09-28 | $170.00 derived: sum of 3 quarters · filed 2021-09-28 | $170.00 derived: sum of 4 quarters · filed 2021-09-28 | |
| 2020-06-30 | $170.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | $170.00 derived: sum of 2 quarters · filed 2021-09-28 | $170.00 derived: sum of 3 quarters · filed 2021-09-28 | $2.00K 10-K · filed 2021-09-28 | $1.83K 10-K · filed 2020-10-06 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-15 | $0.00 derived: sum of 2 quarters · filed 2020-05-15 | $1.83K 10-Q · filed 2021-05-17 | $17.14K derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-12-31 | $0.00 10-Q · filed 2020-02-14 | $1.83K 10-Q · filed 2021-02-11 | $17.14K derived: sum of 3 quarters · filed 2020-11-12 | $14.62K derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-09-30 | $1.83K 10-Q · filed 2020-11-12 | $17.14K derived: sum of 2 quarters · filed 2020-11-12 | $14.62K derived: sum of 3 quarters · filed 2020-11-12 | $35.26K derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | $15.31K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-06 | $12.79K derived: sum of 2 quarters · filed 2020-10-06 | $33.43K derived: sum of 3 quarters · filed 2020-10-06 | $80.78K 10-K · filed 2020-10-06 | -$9.83M 10-K · filed 2019-09-26 |
| 2019-03-31 | -$2.52K 10-Q · filed 2020-05-15 | $18.12K derived: sum of 2 quarters · filed 2020-05-15 | $65.47K 10-Q · filed 2020-05-15 | $2.39M derived: sum of 4 quarters · filed 2020-05-15 | |
| 2018-12-31 | $20.64K 10-Q · filed 2020-02-14 | $67.99K 10-Q · filed 2020-02-14 | $2.39M derived: sum of 3 quarters · filed 2020-02-14 | $5.53M derived: sum of 4 quarters · filed 2020-02-14 | |
| 2018-09-30 | $47.35K 10-Q · filed 2019-11-14 | $2.37M derived: sum of 2 quarters · filed 2019-11-14 | $5.51M derived: sum of 3 quarters · filed 2019-11-14 | $6.03M derived: sum of 4 quarters · filed 2019-11-14 | |
| 2018-06-30 | $2.32M derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-26 | $5.46M derived: sum of 2 quarters · filed 2019-09-26 | $5.98M derived: sum of 3 quarters · filed 2019-09-26 | $6.28M 10-K · filed 2019-09-26 | $3.98M 10-K · filed 2018-09-06 |
| 2018-03-31 | $3.14M 10-Q · filed 2019-05-14 | $3.66M derived: sum of 2 quarters · filed 2019-05-14 | $3.96M 10-Q · filed 2019-05-14 | $3.96M derived: sum of 4 quarters · filed 2019-05-14 | |
| 2017-12-31 | $518.05K 10-Q · filed 2019-05-14 | $817.78K 10-Q · filed 2019-05-14 | $817.78K derived: sum of 3 quarters · filed 2019-05-14 | $834.45K derived: sum of 4 quarters · filed 2019-05-14 | |
| 2017-09-30 | $299.73K 10-Q · filed 2018-11-07 | $299.73K derived: sum of 2 quarters · filed 2018-11-07 | $316.40K derived: sum of 3 quarters · filed 2018-11-07 | $583.15K derived: sum of 4 quarters · filed 2018-11-07 | |
| 2017-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-06 | $16.66K derived: sum of 2 quarters · filed 2018-09-06 | $283.42K derived: sum of 3 quarters · filed 2018-09-06 | $212.81K 10-K · filed 2018-09-06 | |
| 2017-03-31 | $16.66K 10-Q · filed 2018-05-14 | $283.42K derived: sum of 2 quarters · filed 2018-05-14 | $212.81K 10-Q · filed 2018-05-14 | $250.29K derived: sum of 4 quarters · filed 2018-05-14 | |
| 2016-12-31 | $266.76K 10-Q · filed 2018-02-08 | $196.15K 10-Q · filed 2018-02-08 | $233.63K derived: sum of 3 quarters · filed 2018-02-08 | $261.61K derived: sum of 4 quarters · filed 2018-02-08 | |
| 2016-09-30 | -$70.61K 10-Q · filed 2017-11-09 | -$33.13K derived: sum of 2 quarters · filed 2017-11-09 | -$5.14K derived: sum of 3 quarters · filed 2017-11-09 | -$83.31K derived: sum of 4 quarters · filed 2017-11-09 | |
| 2016-06-30 | $37.48K derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-31 | $65.47K derived: sum of 2 quarters · filed 2017-08-31 | -$12.70K derived: sum of 3 quarters · filed 2017-08-31 | -$12.57K 10-K · filed 2017-08-31 | |
| 2016-03-31 | $27.98K 10-Q · filed 2017-05-11 | -$50.18K derived: sum of 2 quarters · filed 2017-05-11 | -$50.05K 10-Q · filed 2017-05-11 | -$50.05K derived: sum of 4 quarters · filed 2017-05-11 | |
| 2015-12-31 | -$78.17K 10-Q · filed 2017-02-09 | -$78.04K 10-Q · filed 2017-02-09 | -$78.04K derived: sum of 3 quarters · filed 2017-02-09 | -$78.04K derived: sum of 4 quarters · filed 2017-02-09 | |
| 2015-09-30 | $128.00 10-Q · filed 2016-11-07 | $128.00 derived: sum of 2 quarters · filed 2016-11-07 | $128.00 derived: sum of 3 quarters · filed 2016-11-07 | $128.00 derived: sum of 4 quarters · filed 2016-11-07 | |
| 2015-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-01 | $0.00 derived: sum of 2 quarters · filed 2016-09-01 | $0.00 derived: sum of 3 quarters · filed 2016-09-01 | $0.00 10-K · filed 2016-09-01 | |
| 2015-03-31 | $0.00 10-Q · filed 2016-05-11 | $0.00 derived: sum of 2 quarters · filed 2016-05-11 | $0.00 10-Q · filed 2016-05-11 | ||
| 2014-12-31 | $0.00 10-Q · filed 2016-02-11 | $0.00 10-Q · filed 2016-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |